AGP Picks
View all

European Ledger
Provided by AGP

European Ledger: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on European Ledger.

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

October 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

November 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30

Press releases published on September 8, 2026

CervoMed to Participate in September Investor Conferences
Sep. 8, 2026

CervoMed to Participate in September Investor Conferences

Indeterminate GlobeNewswire
Nasus Pharma to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Sep. 8, 2026

Nasus Pharma to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire
Domestic Metals Commences Drill Program at Smart Creek Project, Montana
Sep. 8, 2026

Domestic Metals Commences Drill Program at Smart Creek Project, Montana

Indeterminate GlobeNewswire
Pyxis Oncology Appoints Thomas Civik Chief Executive Officer and Chairman of the Board
Sep. 8, 2026

Pyxis Oncology Appoints Thomas Civik Chief Executive Officer and Chairman of the Board

Indeterminate GlobeNewswire
ASML begins construction of new Eindhoven campus, strengthening its presence in the Brainport region
Sep. 8, 2026

ASML begins construction of new Eindhoven campus, strengthening its presence in the Brainport region

Indeterminate GlobeNewswire
Transaction in Own Shares
Sep. 8, 2026

Transaction in Own Shares

Indeterminate GlobeNewswire
Newcore Gold Announces Appointment of Mr. Sulemanu Koney to its Board of Directors
Sep. 8, 2026

Newcore Gold Announces Appointment of Mr. Sulemanu Koney to its Board of Directors

Indeterminate GlobeNewswire
4BIO Capital leads oversubscribed $33 Million Seed Financing of Cloverleaf Bio, Advancing Novel RNA-Based Cancer Therapeutics
Sep. 8, 2026

4BIO Capital leads oversubscribed $33 Million Seed Financing of Cloverleaf Bio, Advancing Novel RNA-Based Cancer Therapeutics

Indeterminate GlobeNewswire
Zenas BioPharma to Host Obexelimab IgG4-RD Investor Event
Sep. 8, 2026

Zenas BioPharma to Host Obexelimab IgG4-RD Investor Event

Indeterminate GlobeNewswire
Invivyd to Participate in Upcoming September Investor Conferences
Sep. 8, 2026

Invivyd to Participate in Upcoming September Investor Conferences

Indeterminate GlobeNewswire
CoinShares Co-Founder and Non-Executive Director Daniel Masters Adopts Pre-Scheduled Trading Plan
Sep. 8, 2026

CoinShares Co-Founder and Non-Executive Director Daniel Masters Adopts Pre-Scheduled Trading Plan

Indeterminate GlobeNewswire
Infex Therapeutics presents new Phase IIa data for RESP-X at ERS Congress 2026, providing further evidence on exploratory efficacy endpoints supporting progression to later stage development
Sep. 8, 2026

Infex Therapeutics presents new Phase IIa data for RESP-X at ERS Congress 2026, providing further evidence on exploratory efficacy endpoints supporting progression to later stage development

Indeterminate GlobeNewswire
G3 Goldfields Provides Update on Listing
Sep. 8, 2026

G3 Goldfields Provides Update on Listing

Indeterminate GlobeNewswire
BrainChild Bio Initiates Pivotal Phase 2 Trial for BCB-276 CAR T cell Therapy for DIPG, a Deadly Pediatric Brain Cancer
Sep. 8, 2026

BrainChild Bio Initiates Pivotal Phase 2 Trial for BCB-276 CAR T cell Therapy for DIPG, a Deadly Pediatric Brain Cancer

Indeterminate GlobeNewswire
BrainChild Bio Closes $116 Million Series A Financing
Sep. 8, 2026

BrainChild Bio Closes $116 Million Series A Financing

Indeterminate GlobeNewswire
Newron Reports Subscription for EUR 5.5 Million of Shares by Investor Group as Part of Up to EUR 38 Million Total Financing to Advance Phase 3 Evenamide Program
Sep. 8, 2026

Newron Reports Subscription for EUR 5.5 Million of Shares by Investor Group as Part of Up to EUR 38 Million Total Financing to Advance Phase 3 Evenamide Program

Indeterminate GlobeNewswire
Lahontan Strengthens Technical, Engineering, and Business Development Team
Sep. 8, 2026

Lahontan Strengthens Technical, Engineering, and Business Development Team

Indeterminate GlobeNewswire
OKYO Pharma to Participate in a Fireside Chat at the Cantor Global Healthcare Conference
Sep. 8, 2026

OKYO Pharma to Participate in a Fireside Chat at the Cantor Global Healthcare Conference

Indeterminate GlobeNewswire
Pharvaris Announces Positive Topline Data from CHAPTER-3 Pivotal Study of Deucrictibant XR for Prophylaxis of HAE Attacks
Sep. 8, 2026

Pharvaris Announces Positive Topline Data from CHAPTER-3 Pivotal Study of Deucrictibant XR for Prophylaxis of HAE Attacks

Indeterminate GlobeNewswire
DPM Metals Extends Mineralization at Dumitru Potok with High-Grade Intercepts
Sep. 8, 2026

DPM Metals Extends Mineralization at Dumitru Potok with High-Grade Intercepts

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

European Ledger

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.